# D23-PART-3 — Final human QA, evidence review, and release

- Status: complete
- Depends on: `D23-PART-2`
- Lane: `integration`

Part 3 is the final human review boundary. It will inspect Part 2 evidence,
repeat the required regression and journey gates, review limitations and
publication restrictions, record a release decision, and authorize merge only
if the evidence supports it. It must not introduce a scheduler, external
provider or LLM, fuzzy matching, look-ahead, broker/order/trade/rebalance
effects, or a representation of investment advice.

Human QA passed, with the recorded evidence in
`docs/workplans/day-2-3/part-3-soft-qa-result.md`. The release documentation
was corrected and the Day 2–3 baseline is complete. No new implementation
scope is activated.
